{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T11:58:50Z","timestamp":1785499130147,"version":"3.56.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum W\u00fcrzburg"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Palliat Care"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Strong opioids are central to effective symptom control in palliative care. In cases of complex symptom burden, primary care teams frequently rely on palliative care consultation services (PCCSs) for expert guidance. This survey explored the recommendations issued by hospital-based PCCS teams regarding the use of strong opioids in patients with advanced disease (e.g. clinical indications, opioid agent).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A closed online survey was conducted via the SoSci Survey platform. All PCCS teams registered with the German Association for Palliative Medicine were invited to participate in November 2024, with a reminder sent three weeks later.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Thirty-nine PCCS teams participated (21 university hospitals, 18 general hospitals). All respondents agreed on the indication for strong opioids in cancer-related pain and dyspnea. Differences emerged regarding the use of opioids in patients with non-malignant conditions: although most PCCS considered opioids appropriate for dyspnea associated with pulmonary (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200937) or cardiac disease (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200933), non-cancer pain was less consistently endorsed (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200920). Hydromorphone and morphine were the most commonly used opioids (&gt;\u200930 services reporting frequent use), whereas the use of fentanyl, oxycodone, and buprenorphine varied widely across services.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>There is consensus regarding the use of opioids in patients with cancer-related pain and dyspnea. The differing approaches to their use for symptoms caused by non-malignant conditions suggest varying clinical interpretations and underscore the need for further research and clearer guidelines.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12904-026-02266-y","type":"journal-article","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T10:49:49Z","timestamp":1785494989000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Practice patterns of strong opioid recommendations by palliative care consultation services in German hospitals (online survey)"],"prefix":"10.1186","volume":"25","author":[{"given":"Evelyn","family":"Mueller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Gahr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Schnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Aulmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Roch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,31]]},"reference":[{"issue":"4","key":"2266_CR1","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.jagp.2016.01.135","volume":"24","author":"EA Meier","year":"2016","unstructured":"Meier EA, Gallegos JV, Thomas LPM, Depp CA, Irwin SA, Jeste DV. Defining a Good Death (Successful Dying): Literature Review and a Call for Research and Public Dialogue. Am J Geriatr Psychiatry. 2016;24(4):261\u201371.","journal-title":"Am J Geriatr Psychiatry"},{"issue":"6","key":"2266_CR2","first-page":"e13708","volume":"31","author":"MJ Verhoef","year":"2022","unstructured":"Verhoef MJ, Sweep B, de Nijs EJM, Valkenburg AC, Horeweg N, Pieterse AH, et al. Assessment of patient symptom burden and information needs helps tailoring palliative care consultations: An observational study. Eur J Cancer Care (Engl). 2022;31(6):e13708.","journal-title":"Eur J Cancer Care (Engl)"},{"issue":"3","key":"2266_CR3","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.pain.2007.08.022","volume":"132","author":"MHJ van den Beuken-van Everdingen","year":"2007","unstructured":"van den Beuken-van Everdingen MHJ, de Rijke JM, Kessels AG, Schouten HC, van Kleef M, Patijn J. High prevalence of pain in patients with cancer in a large population-based study in The Netherlands. Pain. 2007;132(3):312\u201320.","journal-title":"Pain"},{"issue":"4","key":"2266_CR4","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1136\/bmjspcare-2020-002291","volume":"11","author":"E Janberidze","year":"2021","unstructured":"Janberidze E, Pol\u00e1kov\u00e1 K, Bankovsk\u00e1 Motlov\u00e1 L, Lou\u010dka M. Impact of palliative care consult service in inpatient hospital setting: a systematic literature review. BMJ Support Palliat Care. 2021;11(4):351.","journal-title":"BMJ Support Palliat Care"},{"issue":"1","key":"2266_CR5","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jpainsymman.2023.09.015","volume":"67","author":"K Tagami","year":"2024","unstructured":"Tagami K, Chiu SW, Kosugi K, Ishiki H, Hiratsuka Y, Shimizu M, et al. Cancer Pain Management in Patients Receiving Inpatient Specialized Palliative Care Services. J Pain Symptom Manage. 2024;67(1):27\u2013e381.","journal-title":"J Pain Symptom Manage"},{"issue":"2","key":"2266_CR6","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s00940-018-0771-0","volume":"34","author":"MA \u00dcberall","year":"2018","unstructured":"\u00dcberall MA, M\u00fcller-Schwefe GHH. Status quo der Behandlung tumorbedingter Dauer- und Durchbruchschmerzen in Deutschland. Schmerzmed. 2018;34(2):38\u201348.","journal-title":"Schmerzmed"},{"issue":"7","key":"2266_CR7","first-page":"CD012592","volume":"7","author":"PJ Wiffen","year":"2017","unstructured":"Wiffen PJ, Wee B, Derry S, Bell RF, Moore RA. Opioids for cancer pain - an overview of Cochrane reviews. Cochrane Database Syst Rev. 2017;7(7):CD012592.","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"2266_CR8","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1007\/s10147-023-02362-6","volume":"28","author":"Y Takagi","year":"2023","unstructured":"Takagi Y, Sato J, Yamamoto Y, Matsunuma R, Watanabe H, Mori M, et al. Opioids for the management of dyspnea in cancer patients: a systematic review and meta-analysis. Int J Clin Oncol. 2023;28(8):999\u20131010.","journal-title":"Int J Clin Oncol"},{"key":"2266_CR9","doi-asserted-by":"crossref","unstructured":"Sivanathan V, Smallwood N, Strathmore A, Johnson D, Le B, Zentner D. The Palliative Approach and Terminal Heart Failure Admissions - Are We Getting it Right? Heart Lung Circ. 2022;31(6):841\u20138.","DOI":"10.1016\/j.hlc.2022.01.002"},{"issue":"9","key":"2266_CR10","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1200\/JCO.18.02123","volume":"38","author":"D Hui","year":"2020","unstructured":"Hui D, Bruera E. Models of Palliative Care Delivery for Patients With Cancer. JCO. 2020;38(9):852\u201365.","journal-title":"JCO"},{"key":"2266_CR11","unstructured":"Leitlinienprogramm Onkologie der Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften e. V. (AWMF). Deutschen Krebsgesellschaft e. V. (DKG) und Deutschen Krebshilfe. S3-Leitlinie Palliativmedizin f\u00fcr Patienten mit einer nicht heilbaren Krebserkrankung. Version 2. 2019. https:\/\/www.awmf.org\/leitlinien\/detail\/ll\/128-001OL.html. Accessed 12 Dec 2026."},{"issue":"2","key":"2266_CR12","doi-asserted-by":"publisher","first-page":"e58","DOI":"10.1016\/S1470-2045(12)70040-2","volume":"13","author":"A Caraceni","year":"2012","unstructured":"Caraceni A, Hanks G, Kaasa S, Bennett MI, Brunelli C, Cherny N, et al. Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. Lancet Oncol. 2012;13(2):e58\u201368.","journal-title":"Lancet Oncol"},{"key":"2266_CR13","first-page":"63","volume-title":"Cancer pain relief: with a guide to opioid availability","author":"World Health Organisation","year":"1996","unstructured":"World Health Organisation. Cancer pain relief: with a guide to opioid availability. 2 ed. Geneva: World Health Organization; 1996. p. 63.","edition":"2"},{"issue":"14","key":"2266_CR14","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1136\/heartjnl-2022-322074","volume":"109","author":"J Gaertner","year":"2023","unstructured":"Gaertner J, Fusi-Schmidhauser T, Stock S, Siemens W, Vennedey V. Effect of opioids for breathlessness in heart failure: a systematic review and meta-analysis. Heart. 2023;109(14):1064\u201371.","journal-title":"Heart"},{"issue":"3","key":"2266_CR15","first-page":"CD011008","volume":"3","author":"H Barnes","year":"2016","unstructured":"Barnes H, McDonald J, Smallwood N, Manser R. Opioids for the palliation of refractory breathlessness in adults with advanced disease and terminal illness. Cochrane Database Syst Rev. 2016;3(3):CD011008.","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"2266_CR16","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1097\/SPC.0000000000000509","volume":"14","author":"D Hui","year":"2020","unstructured":"Hui D, Bruera E. Use of short-acting opioids in the management of breathlessness: an evidence-based review. Curr Opin Supportive Palliat Care. 2020;14(3):167\u201376.","journal-title":"Curr Opin Supportive Palliat Care"},{"issue":"20","key":"2266_CR17","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s15006-024-4386-1","volume":"166","author":"C R\u00e9mi","year":"2024","unstructured":"R\u00e9mi C, B\u00fcsel S, P\u00fcgge S, Dukic-Ott A. [Off-label-use in palliative care]. MMW Fortschr Med. 2024;166(20):40\u20133.","journal-title":"MMW Fortschr Med"},{"issue":"3","key":"2266_CR18","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/j.1533-2500.2008.00189.x","volume":"8","author":"CCAHHVM Verhagen","year":"2008","unstructured":"Verhagen CCAHHVM, Niezink AGH, Engels YY, Hekster YYA, Doornebal JJ, Vissers KCP. Off-label use of drugs in pain medicine and palliative care: an algorithm for the assessment of its safe and legal prescription. Pain Pract. 2008;8(3):157\u201363.","journal-title":"Pain Pract"},{"issue":"4","key":"2266_CR19","doi-asserted-by":"publisher","first-page":"490","DOI":"10.21037\/apm.2019.08.01","volume":"8","author":"J Gaertner","year":"2019","unstructured":"Gaertner J, Boehlke C, Simone CB, Hui D. Early palliative care and the opioid crisis: ten pragmatic steps towards a more rational use of opioids. Ann Palliat Med. 2019;8(4):490\u20137.","journal-title":"Ann Palliat Med"},{"issue":"12","key":"2266_CR20","first-page":"1147","volume":"80","author":"MA Marchetti Cal\u00f4nego","year":"2020","unstructured":"Marchetti Cal\u00f4nego MA, Sikandar S, Ferris FD, Moreira de Barros GA. Spread Word: There Are Two Opioid Crises! Drugs. 2020;80(12):1147\u201354.","journal-title":"Spread Word: There Are Two Opioid Crises! Drugs"},{"key":"2266_CR21","unstructured":"B\u00fcrgerliches, Gesetzbuch. (BGB), \u00a7 630a Patientenrechtegesetz. https:\/\/www.gesetze-im-internet.de\/bgb\/__630a.htm. Accessed 26 Feb 2026."},{"issue":"10","key":"2266_CR22","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1089\/jpm.2022.0266","volume":"25","author":"A Reddy","year":"2022","unstructured":"Reddy A, Sinclair C, Crawford GB, McPherson ML, Mercadante S, Hui D, et al. Opioid Rotation and Conversion Ratios Used by Palliative Care Professionals: An International Survey. J Palliat Med. 2022;25(10):1557\u201362.","journal-title":"J Palliat Med"},{"issue":"1","key":"2266_CR23","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12904-023-01291-5","volume":"23","author":"C Volberg","year":"2024","unstructured":"Volberg C, Schmidt-Semisch H, Maul J, Nadig J, Gschnell M. Pain management in German hospices: a cross-sectional study. BMC Palliat Care. 2024;23(1):7.","journal-title":"BMC Palliat Care"},{"key":"2266_CR24","unstructured":"Leiner DJ. SoSci Survey (Version 3.5.01). 2024. https:\/\/www.soscisurvey.de."},{"issue":"3","key":"2266_CR25","doi-asserted-by":"publisher","first-page":"e34","DOI":"10.2196\/jmir.6.3.e34","volume":"6","author":"G Eysenbach","year":"2004","unstructured":"Eysenbach G. Improving the quality of Web surveys: the Checklist for Reporting Results of Internet E-Surveys (CHERRIES). J Med Internet Res. 2004;6(3):e34.","journal-title":"J Med Internet Res"},{"issue":"1","key":"2266_CR26","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1186\/s12904-025-01921-0","volume":"24","author":"E Mueller","year":"2025","unstructured":"Mueller E, Gahr S, Schnell A, Schildmann E, Boehlke C, Roch C. Challenges in opioid therapy implementation: national survey of palliative care consultation services. BMC Palliat Care. 2025;24(1):262.","journal-title":"BMC Palliat Care"},{"key":"2266_CR27","volume-title":"IBM SPSS Statistics for Windows","author":"IBM Corp","year":"2021","unstructured":"IBM Corp. IBM SPSS Statistics for Windows. Armonk, NY: IBM Corp; 2021."},{"key":"2266_CR28","doi-asserted-by":"publisher","first-page":"411","DOI":"10.2147\/JPR.S244173","volume":"13","author":"J Yang","year":"2020","unstructured":"Yang J, Bauer BA, Wahner-Roedler DL, Chon TY, Xiao L. The Modified WHO Analgesic Ladder: Is It Appropriate for Chronic Non-Cancer Pain? J Pain Res. 2020;13:411\u20137.","journal-title":"J Pain Res"},{"issue":"8","key":"2266_CR29","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1002\/ejp.1786","volume":"25","author":"W H\u00e4user","year":"2021","unstructured":"H\u00e4user W, Buchser E, Finn DP, Dom G, Fors E, Heiskanen T, et al. Is Europe also facing an opioid crisis?-A survey of European Pain Federation chapters. Eur J Pain. 2021;25(8):1760\u20139.","journal-title":"Eur J Pain"},{"key":"2266_CR30","unstructured":"Anekar AA, Hendrix JM, Cascella M. WHO Analgesic Ladder. In: StatPearls. Treasure Island (FL): StatPearls Publishing; https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK554435\/. Accessed 26. Feb 2026."},{"issue":"174","key":"2266_CR31","doi-asserted-by":"publisher","first-page":"230265","DOI":"10.1183\/16000617.0265-2023","volume":"33","author":"NE Smallwood","year":"2024","unstructured":"Smallwood NE, Pascoe A, Wijsenbeek M, Russell AM, Holland AE, Romero L, et al. Opioids for the palliation of symptoms in people with serious respiratory illness: a systematic review and meta-analysis. Eur Respir Rev. 2024;33(174):230265.","journal-title":"Eur Respir Rev"},{"issue":"e3","key":"2266_CR32","doi-asserted-by":"publisher","first-page":"e715","DOI":"10.1136\/spcare-2022-004115","volume":"13","author":"T Sakaguchi","year":"2024","unstructured":"Sakaguchi T. Cancer-related breathlessness: opioids other than morphine - comprehensive literature review. BMJ Support Palliat Care. 2024;13(e3):e715\u201329.","journal-title":"BMJ Support Palliat Care"},{"issue":"e6","key":"2266_CR33","doi-asserted-by":"publisher","first-page":"e792","DOI":"10.1136\/bmjspcare-2018-001560","volume":"12","author":"D See","year":"2022","unstructured":"See D, Le B, Gorelik A, Eastman P. Symptom burden in malignant and non-malignant disease on admission to a palliative care unit. BMJ Support Palliat Care. 2022;12(e6):e792\u20137.","journal-title":"BMJ Support Palliat Care"},{"issue":"3","key":"2266_CR34","doi-asserted-by":"publisher","first-page":"513","DOI":"10.21037\/apm-23-565","volume":"13","author":"GA Fordjour","year":"2024","unstructured":"Fordjour GA, Chow AYM, Hui VKY, Chan CLW. Comparative analysis of symptom burdens and influential factors among diverse terminally-ill patients. Ann Palliat Med. 2024;13(3):513\u201330.","journal-title":"Ann Palliat Med"},{"key":"2266_CR35","unstructured":"Bhatnagar M, Pruskowski J. Opioid Equivalency. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2025. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK535402\/ PubMed. Accessed 16 Feb 2026."},{"issue":"7","key":"2266_CR36","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/S0025-6196(11)60750-7","volume":"84","author":"HS Smith","year":"2009","unstructured":"Smith HS. Opioid metabolism. Mayo Clin Proc. 2009;84(7):613\u201324.","journal-title":"Mayo Clin Proc"},{"issue":"4","key":"2266_CR37","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1080\/15360288.2023.2257674","volume":"37","author":"J Fleckner","year":"2023","unstructured":"Fleckner J, Pettus K, Vallath N, Pastrana T. Systematic Review on Barriers to Access Opioid Analgesics for Cancer Pain Management from the Health Worker Perspective. J Pain Palliat Care Pharmacother. 2023;37(4):324\u201335.","journal-title":"J Pain Palliat Care Pharmacother"},{"issue":"8","key":"2266_CR38","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.ejpain.2007.01.003","volume":"11","author":"S Mercadante","year":"2007","unstructured":"Mercadante S. Opioid titration in cancer pain: A critical review. Eur J Pain. 2007;11(8):823\u201330.","journal-title":"Eur J Pain"},{"key":"2266_CR39","doi-asserted-by":"publisher","first-page":"233","DOI":"10.2147\/DDDT.S414318","volume":"18","author":"Q Fu","year":"2024","unstructured":"Fu Q, Han N, Li N, Gui L, Shi C, Rong P, et al. Guidelines for Rational Clinical Use of Fentanyl Transdermal Patch. DDDT. 2024;18:233\u201355.","journal-title":"DDDT"},{"issue":"2","key":"2266_CR40","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1080\/17425255.2020.1721458","volume":"16","author":"R Balyan","year":"2020","unstructured":"Balyan R, Hahn D, Huang H, Chidambaran V. Pharmacokinetic and pharmacodynamic considerations in developing a response to the opioid epidemic. Expert Opin Drug Metab Toxicol. 2020;16(2):125\u201341.","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"2266_CR41","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1093\/annonc\/mdy152","volume":"29","author":"M Fallon","year":"2018","unstructured":"Fallon M, Giusti R, Aielli F, Hoskin P, Rolke R, Sharma M, et al. Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines. Ann Oncol. 2018;29:166\u201391.","journal-title":"Ann Oncol"},{"key":"2266_CR42","unstructured":"Preuss CV, Kalava A, King KC. Prescription of Controlled Substances: Benefits and Risks. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2025. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK537318\/ PubMed. Accessed 19 Feb 2025."},{"key":"2266_CR43","unstructured":"Bundes\u00e4rztekammer. (Muster-)Berufsordnung f\u00fcr die in Deutschland t\u00e4tigen \u00c4rztinnen und \u00c4rzte (MBO-\u00c4). Beschluss des 130. Deutschen \u00c4rztetages vom 13. Mai 2026. \u00a7 15 Forschung. Berlin: Bundes\u00e4rztekammer. 2026. https:\/\/www.bundesaerztekammer.de\/fileadmin\/user_upload\/BAEK\/Themen\/Recht\/2026-06-18_Bek_BAEK_Musterberufsordnung_-_MBO.pdf. Accessed 16 Jul 2026."}],"container-title":["BMC Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12904-026-02266-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12904-026-02266-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12904-026-02266-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T11:16:06Z","timestamp":1785496566000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12904-026-02266-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,31]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2266"],"URL":"https:\/\/doi.org\/10.1186\/s12904-026-02266-y","relation":{},"ISSN":["1472-684X"],"issn-type":[{"value":"1472-684X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,31]]},"assertion":[{"value":"1 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"According to \u00a7 15 of the Professional Code for Physicians of the respective State Medical Association, ethics committee review is required for research involving interventions on humans or the use of identifiable human data or biological material [\n                      \n                      ]. Given the anonymous nature of the survey of healthcare professionals and the absence of patient health data, no ethics approval was necessary. Participation was voluntary and we have obtained informed consent during the submission process from all participants to participate in the study. No data identifying respondents or PCCS were collected. The study was conducted in accordance with the principles of the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"<b>Consent for publication<\/b>","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"<b>Competing interests<\/b>","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"223"}}